Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
about
Metabolism Is Central to Tolerogenic Dendritic Cell FunctionFeasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MiceThe anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy.Mechanism of antineoplastic activity of lonidamine.Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities.Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism.Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B.2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.Drug repurposing for the treatment of glioblastoma multiforme.The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations.Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
P2860
Q26765348-02407050-AE54-476D-9BE5-DBA75B06DF2EQ33598925-4C5A7FDE-A38B-47E6-B145-CB3DD7B45B80Q36048258-0A3C2EE5-6216-4617-9EA6-60BBE44D8435Q36746415-D51526B0-2E8C-4274-87D8-55F6FEB10A71Q36955054-0BDDFADD-8712-4F41-BCB3-302332CD4460Q37004918-0F663EE1-29FC-4C13-9A67-2219CBE3F3C0Q38786015-44C89948-79A5-49E6-9894-2AD7FD10FD9CQ38920583-60B6E421-7B4D-4780-A87B-0C386180D127Q41040111-E0D89D74-3D22-4562-A3B8-9F1C11B064E1Q42247264-2F538FF2-10EE-493B-B260-91ADCD2D34ECQ47164149-29516030-E7CA-4D1C-9557-2F84A01DF19CQ47257443-B8F5B906-226E-4607-985E-E9E3CDFBF4DAQ47914208-05043AAC-C943-46B6-9644-FF51C624C331Q47948290-D4498EB8-AD52-4D47-9FB7-F9D41D1BEFE3Q55100676-F3B04EA9-C7BB-4556-84D8-EBCE769170E0Q57050141-4476A378-230B-4B37-87E2-BE00300154A6
P2860
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@ast
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@en
type
label
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@ast
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@en
prefLabel
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@ast
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@en
P2093
P2860
P356
P1476
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
@en
P2093
Alexander A Shestov
Andrew J Worth
David S Nelson
Dennis B Leeper
Ian A Blair
Jerry D Glickson
Kavindra Nath
P2860
P356
10.1074/JBC.M115.697516
P407
P577
2015-10-31T00:00:00Z